Viracta Therapeutics, Inc.
VIRX
$0.0158
-$0.001-5.95%
OTC PK
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -7.36% | -7.54% | 33.59% | -9.25% | -0.93% |
| Total Depreciation and Amortization | 14.58% | -12.73% | -10.57% | -3.91% | 7.56% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -2.34% | -23.13% | 14.59% | 4.05% | -12.58% |
| Change in Net Operating Assets | 278.49% | -291.82% | -113.79% | 239.62% | -76.87% |
| Cash from Operations | 27.82% | -25.20% | 21.72% | 4.82% | -31.85% |
| Capital Expenditure | -- | -- | -- | -100.00% | 126.98% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -30.27% | -17.54% | 53.10% | 2.46% | 117.01% |
| Cash from Investing | -30.27% | -17.54% | 53.10% | 1.89% | 128.59% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -192,000.00% | 99.99% | -- | -- | -- |
| Issuance of Common Stock | -100.00% | -45.00% | -63.30% | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -4,567.44% | 100.65% | -3,126.61% | -- | -100.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -144.50% | 852.55% | 52.69% | 62.49% | 62.24% |